// App-Quantinova.ai

: EGFR ligand expression levels and detriment from cetuximab in patients with operable liver metastases from colorectal cancer

Researchers

Presenter

  • S.A. Pugh

Principal Investigators

  • J.A. Bridgewater

Medical Centers

  • University of Southampton,

  • University College London Cancer Institute, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Secondary liver cancer

  • Solid malignancies

Biomarkers

  • Amphiregulin

  • Epidermal growth factor receptor

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Erbitux

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved